Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

BUY
$14.1 - $19.83 $410,874 - $577,846
29,140 Added 12.49%
262,507 $4.22 Million
Q1 2023

May 15, 2023

BUY
$9.09 - $19.45 $2.12 Million - $4.54 Million
233,367 New
233,367 $4.06 Million
Q1 2021

May 14, 2021

SELL
$41.56 - $59.88 $5.25 Million - $7.56 Million
-126,241 Closed
0 $0
Q4 2020

Feb 17, 2021

SELL
$36.08 - $56.47 $4.34 Million - $6.8 Million
-120,356 Reduced 48.81%
126,241 $6.8 Million
Q3 2020

Nov 16, 2020

SELL
$33.26 - $40.48 $2.76 Million - $3.35 Million
-82,849 Reduced 25.15%
246,597 $9.1 Million
Q2 2020

Aug 14, 2020

SELL
$24.21 - $31.02 $636,093 - $815,019
-26,274 Reduced 7.39%
329,446 $10.2 Million
Q1 2020

May 13, 2020

SELL
$20.5 - $34.53 $223,573 - $376,584
-10,906 Reduced 2.97%
355,720 $9.82 Million
Q4 2019

Feb 14, 2020

SELL
$18.96 - $29.84 $2.58 Million - $4.05 Million
-135,875 Reduced 27.04%
366,626 $10.7 Million
Q3 2019

Nov 15, 2019

SELL
$19.12 - $26.24 $1.43 Million - $1.96 Million
-74,620 Reduced 12.93%
502,501 $9.61 Million
Q2 2019

Aug 13, 2019

SELL
$19.57 - $24.1 $1.65 Million - $2.04 Million
-84,494 Reduced 12.77%
577,121 $12.7 Million
Q1 2019

May 14, 2019

SELL
$12.14 - $20.46 $153,194 - $258,184
-12,619 Reduced 1.87%
661,615 $13.5 Million
Q4 2018

Feb 12, 2019

BUY
$11.24 - $18.5 $4.31 Million - $7.09 Million
383,300 Added 131.75%
674,234 $8.5 Million
Q3 2018

Nov 15, 2018

BUY
$12.5 - $15.38 $3.64 Million - $4.47 Million
290,934 New
290,934 $4.47 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.8B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.